QQQ   306.36 (+0.74%)
AAPL   119.99 (-0.12%)
MSFT   231.92 (+2.29%)
FB   260.08 (+0.95%)
GOOGL   2,068.40 (+1.69%)
TSLA   593.59 (-4.48%)
AMZN   2,975.03 (-0.09%)
NVDA   495.41 (+0.12%)
BABA   232.71 (+0.96%)
CGC   30.61 (-1.29%)
GE   13.49 (-0.59%)
MU   88.13 (+4.51%)
NIO   36.70 (-6.57%)
AMD   78.06 (+0.40%)
T   29.57 (+2.25%)
F   12.13 (+1.68%)
ACB   9.40 (-4.28%)
DIS   188.89 (+0.46%)
BA   220.23 (-1.99%)
NFLX   510.35 (-0.18%)
BAC   36.74 (+0.66%)
QQQ   306.36 (+0.74%)
AAPL   119.99 (-0.12%)
MSFT   231.92 (+2.29%)
FB   260.08 (+0.95%)
GOOGL   2,068.40 (+1.69%)
TSLA   593.59 (-4.48%)
AMZN   2,975.03 (-0.09%)
NVDA   495.41 (+0.12%)
BABA   232.71 (+0.96%)
CGC   30.61 (-1.29%)
GE   13.49 (-0.59%)
MU   88.13 (+4.51%)
NIO   36.70 (-6.57%)
AMD   78.06 (+0.40%)
T   29.57 (+2.25%)
F   12.13 (+1.68%)
ACB   9.40 (-4.28%)
DIS   188.89 (+0.46%)
BA   220.23 (-1.99%)
NFLX   510.35 (-0.18%)
BAC   36.74 (+0.66%)
QQQ   306.36 (+0.74%)
AAPL   119.99 (-0.12%)
MSFT   231.92 (+2.29%)
FB   260.08 (+0.95%)
GOOGL   2,068.40 (+1.69%)
TSLA   593.59 (-4.48%)
AMZN   2,975.03 (-0.09%)
NVDA   495.41 (+0.12%)
BABA   232.71 (+0.96%)
CGC   30.61 (-1.29%)
GE   13.49 (-0.59%)
MU   88.13 (+4.51%)
NIO   36.70 (-6.57%)
AMD   78.06 (+0.40%)
T   29.57 (+2.25%)
F   12.13 (+1.68%)
ACB   9.40 (-4.28%)
DIS   188.89 (+0.46%)
BA   220.23 (-1.99%)
NFLX   510.35 (-0.18%)
BAC   36.74 (+0.66%)
QQQ   306.36 (+0.74%)
AAPL   119.99 (-0.12%)
MSFT   231.92 (+2.29%)
FB   260.08 (+0.95%)
GOOGL   2,068.40 (+1.69%)
TSLA   593.59 (-4.48%)
AMZN   2,975.03 (-0.09%)
NVDA   495.41 (+0.12%)
BABA   232.71 (+0.96%)
CGC   30.61 (-1.29%)
GE   13.49 (-0.59%)
MU   88.13 (+4.51%)
NIO   36.70 (-6.57%)
AMD   78.06 (+0.40%)
T   29.57 (+2.25%)
F   12.13 (+1.68%)
ACB   9.40 (-4.28%)
DIS   188.89 (+0.46%)
BA   220.23 (-1.99%)
NFLX   510.35 (-0.18%)
BAC   36.74 (+0.66%)
Log in
LON:PEBI

Port Erin Biopharma Investments Share Forecast, Price & News

GBX 4.50
+4.50 (+∞)
(As of 04/18/2019)
Add
Compare
Today's Range
4.50
Now: GBX 4.50
4.50
50-Day Range
4.50
MA: GBX 4.50
4.50
52-Week Range
3.15
Now: GBX 4.50
6
Volume8,294 shs
Average Volume43,123 shs
Market Capitalization£1.04 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Port Erin Biopharma Investments Limited is a principal investment firm specializing in investments in equity and equity related products. The firm invests in quoted and unquoted companies. It prefers to invest in the biopharma sector and will establish a portfolio of investments in biotechnology and biopharmaceutical companies. The firm may also invest in shares of collective investment schemes with exposure to the biopharma sector and in long-term equity anticipation securities the underlying securities of which will be based on biopharma sector securities and/or indices relating to the biopharma Sector. It may invest in biopharma sector debt, where investments shall not exceed 15 per cent of the net asset value of the company. Port Erin Biopharma Investments Limited was founded on May 3, 2011 and is based in Isle of Man, United Kingdom.

Headlines

No headlines for this company have been tracked by MarketBeat.com

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+44-1624-620711
EmployeesN/A
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£28,300.00
Cash FlowGBX 8.20 per share
Book ValueGBX 8.10 per share

Profitability

Miscellaneous

Market Cap£1.04 million
Next Earnings DateN/A
OptionableNot Optionable

MarketRank

Overall MarketRank

0.63 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -
GBX 4.50
+4.50 (+∞)
(As of 04/18/2019)
30 days | 90 days | 365 days | Advanced Chart

Receive PEBI News and Ratings via Email

Sign-up to receive the latest news and ratings for PEBI and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Port Erin Biopharma Investments (LON:PEBI) Frequently Asked Questions

What stocks does MarketBeat like better than Port Erin Biopharma Investments?

Wall Street analysts have given Port Erin Biopharma Investments a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Port Erin Biopharma Investments wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are Port Erin Biopharma Investments' key executives?

Port Erin Biopharma Investments' management team includes the following people:
  • Mr. Denham Hervey Newall Eke, CFO, Fin. Director & Director (Age 67)

Who are some of Port Erin Biopharma Investments' key competitors?

What is Port Erin Biopharma Investments' stock symbol?

Port Erin Biopharma Investments trades on the London Stock Exchange (LON) under the ticker symbol "PEBI."

How do I buy shares of Port Erin Biopharma Investments?

Shares of PEBI and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Port Erin Biopharma Investments' stock price today?

One share of PEBI stock can currently be purchased for approximately GBX 4.50.

How much money does Port Erin Biopharma Investments make?

Port Erin Biopharma Investments has a market capitalization of £1.04 million and generates £28,300.00 in revenue each year.

What is Port Erin Biopharma Investments' official website?

The official website for Port Erin Biopharma Investments is www.porterinbiopharma.com.

Where are Port Erin Biopharma Investments' headquarters?

Port Erin Biopharma Investments is headquartered at 18 Athol Street, DOUGLAS, IM1 1JA, Isle of Man.

How can I contact Port Erin Biopharma Investments?

Port Erin Biopharma Investments' mailing address is 18 Athol Street, DOUGLAS, IM1 1JA, Isle of Man. The company can be reached via phone at +44-1624-620711.


This page was last updated on 3/5/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.